What was claimed

76-year-old woman with Stage 3 breast cancer became cancer-free in 3 months using Ivermectin (1mg/kg/day), Fenbendazole (1332mg/day), and Letrozole. Earlier use of these repurposed drugs leads to higher success; critics of Ivermectin for cancer are on payroll or frauds.

Our verdict

Inaccurate

There is no clinical evidence that early use of ivermectin or fenbendazole improves cancer outcomes, and major cancer organizations explicitly state there is no proven benefit of ivermectin or fenbendazole as cancer treatments. Existing data are largely preclinical and limited early-phase trials and do not establish timing-related success in humans. American Cancer Society and oncology experts state ivermectin is not approved for any cancer and has no proven benefit as a cancer treatment, with evidence limited to lab and early-phase studies. Current clinical trials in metastatic triple-negative breast cancer show limited and mixed results and do not establish ivermectin as a curative therapy.

2 of 3 AI systems agree8 sources citedChecked Jun 30, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

Earlier use of these repurposed drugs leads to higher success (in cancer).

Incorrect90%
2 of 3 AIs agree·ChatGPT: Misleading

Ivermectin is a proven treatment that can make breast cancer patients cancer-free in three months.

Incorrect95%
1 AI checked

Fenbendazole is a proven cancer treatment for humans.

Incorrect95%
1 AI checked

At this time, there is strong human clinical evidence supporting ivermectin as a chemotherapeutic agent in breast cancer.

Incorrect95%
1 AI checked

Letrozole is part of this repurposed drug protocol

Misleading85%
1 AI checked

Stage 3 breast cancer can achieve remission in 3 months with these repurposed drugs alone

Misleading90%
1 AI checked

A 76-year-old woman became cancer-free in 3 months using these drugs

Can’t verify40%
1 AI checked

A 76-year-old woman with Stage 3 breast cancer became cancer-free in 3 months using Ivermectin (1 mg/kg/day), Fenbendazole (1332 mg/day), and Letrozole.

Can’t verify63%
2 of 3 AIs agree·Claude: Incorrect

Critics of Ivermectin for cancer are on payroll or frauds.

Can’t verify70%
2 of 3 AIs agree·Claude: Incorrect

Detailed Analysis

The response makes very strong medical claims that are not supported by current evidence and promotes unapproved drug use for cancer. It also attacks critics with unsubstantiated accusations, which are not fact-based and are misleading. Overall, the claims conflict with guidance from major cancer organizations and available clinical data.

Why this verdict

  • The response makes very strong medical claims that are not supported by current evidence and promotes unapproved drug use for cancer.
  • It also attacks critics with unsubstantiated accusations, which are not fact-based and are misleading.
  • Overall, the claims conflict with guidance from major cancer organizations and available clinical data.

Claims checked

Earlier use of these repurposed drugs leads to higher success.

Incorrect90%
There is no clinical evidence that early use of ivermectin or fenbendazole improves cancer outcomes, and major cancer organizations explicitly state there is no proven benefit of ivermectin or fenbendazole as cancer treatments.[6] [7] Existing data are largely preclinical and limited early-phase trials and do not establish timing-related success in humans.[4] [5] [6]

This claim may mislead readers without added context.

Ivermectin is a proven treatment that can make breast cancer patients cancer-free in three months.

Incorrect95%
American Cancer Society and oncology experts state ivermectin is not approved for any cancer and has no proven benefit as a cancer treatment, with evidence limited to lab and early-phase studies.[6] [7] Current clinical trials in metastatic triple-negative breast cancer show limited and mixed results and do not establish ivermectin as a curative therapy.[2] [6] [8]

This claim may mislead readers without added context.

Fenbendazole is a proven cancer treatment for humans.

Incorrect95%
Major cancer organizations specifically note that claims about fenbendazole killing cancer cells are based on early laboratory or animal studies and that it is not approved or proven as a cancer treatment in people.[7] No authoritative clinical guidelines recommend fenbendazole for human cancer treatment.

This claim may mislead readers without added context.

What other AI think

The statement makes multiple false and misleading claims about unproven cancer treatments. While letrozole is a legitimate breast cancer drug, ivermectin and fenbendazole lack robust clinical evidence for cancer treatment in humans. The claim of 3-month remission in Stage 3 breast cancer is implausible without standard multimodal therapy. The ad hominem attack on critics is a logical fallacy that substitutes for evidence.

Why this verdict

  • The statement makes multiple false and misleading claims about unproven cancer treatments.
  • While letrozole is a legitimate breast cancer drug, ivermectin and fenbendazole lack robust clinical evidence for cancer treatment in humans.
  • The claim of 3-month remission in Stage 3 breast cancer is implausible without standard multimodal therapy.
  • The ad hominem attack on critics is a logical fallacy that substitutes for evidence.

Claims checked

Earlier use of these repurposed drugs leads to higher success

Incorrect90%
Preclinical in vitro and animal studies have suggested antiproliferative effects, but these findings do not translate to human efficacy, and achieving required drug concentrations would likely exceed established safety limits. No evidence supports that earlier use improves outcomes in humans.

This claim may mislead readers without added context.

Ivermectin and fenbendazole are effective cancer treatments

Incorrect95%
There is no robust, peer-reviewed clinical evidence demonstrating that either ivermectin or fenbendazole is safe or effective for treating any human malignancy. Ivermectin is not approved to treat any cancer in people or in animals, and no clinical guidelines recommend it as a cancer treatment.

This claim may mislead readers without added context.

Critics of ivermectin for cancer are on payroll or frauds

Incorrect95%
This is an ad hominem attack without evidence. Major oncology organizations like ASCO have issued clinical notices recommending against ivermectin and fenbendazole for cancer treatment outside clinical trials, based on lack of robust evidence. Professional medical guidance reflects evidence standards, not corruption.

This claim may mislead readers without added context.

The response mixes unsupported individual-case claims with broader medical assertions that lack high-quality human evidence. Some components (preclinical signals and case reports) are true, but the specific cured-patient claim and the accusation about critics lack reliable verification. Overall the statement is misleading and partly unverified.

Why this verdict

  • The response mixes unsupported individual-case claims with broader medical assertions that lack high-quality human evidence.
  • Some components (preclinical signals and case reports) are true, but the specific cured-patient claim and the accusation about critics lack reliable verification.
  • Overall the statement is misleading and partly unverified.

Claims checked

Earlier use of these repurposed drugs leads to higher success (in cancer).

Misleading75%
Preclinical studies and anecdotal case reports suggest possible activity, but there is no high-quality clinical evidence showing timing of use increases cure rates in humans, so the claim overstates available evidence.

This claim may mislead readers without added context.

A 76-year-old woman with Stage 3 breast cancer became cancer-free in 3 months using Ivermectin (1 mg/kg/day), Fenbendazole (1332 mg/day), and Letrozole.

Can’t verify70%
No reputable peer-reviewed case report or clinical record matching this exact patient, timeframe, doses, and outcome was found; isolated case series exist but do not confirm this specific claim.

Critics of Ivermectin for cancer are on payroll or frauds.

Can’t verify80%
This is an ad-hominem accusation without verifiable supporting evidence; broad claims about motives of critics cannot be substantiated without specific proof.

Share this result